School of Medicine


Showing 4,251-4,300 of 12,892 Results

  • T. Kyle Harrison, MD

    T. Kyle Harrison, MD

    Staff, Anesthesia - Adult Pain Medicine
    Clinical Professor (Affiliated), Multispecialty Anesthesiology

    BioDr. T. Kyle Harrison is a Clinical Professor (Affiliated- PAVA) of Anesthesiology, Perioperative and Pain Medicine at Stanford University and a staff physician at the VA Palo Alto. He is board certified in both Anesthesiology and Addiction Medicine. He earned his MD and did his residency training in anesthesiology at Stanford University. He completed a medical education and simulation fellowship at Stanford and then obtained additional training in addiction medicine at both Stanford and the VA Palo Alto. He is interested in the intersection of pain and addiction. He co directs the Transitional Pain Clinic at the VA Palo Alto. He attends on both the acute pain service as well as the addiction medicine clinic at the VA Palo Alto. His academic interest include addiction, pain, peri operative management of buprenorphine, transitional pain, conversion of acute to chronic pain, and medical simulation. His email is kyle.harrison@stanford.edu and his twitter handle is @KyleHarrisonMD.

  • Geoffrey Hart-Cooper

    Geoffrey Hart-Cooper

    Clinical Associate Professor, Pediatrics - General Pediatrics

    Current Research and Scholarly InterestsDr. Hart-Cooper's research focuses on youth provider barriers and education surrounding pre-exposure prophylaxis for HIV (PrEP). He founded the Virtual PrEP Program for Adolescents and Young Adults at Stanford to improve access to PrEP care for youth within California. In his current role, he advises health departments and health systems in creating youth-focused telehealth tools to improve youth access to PrEP.

  • Phillip M. Harter, M.D.

    Phillip M. Harter, M.D.

    Associate Professor (Teaching) of Emergency Medicine, Emeritus

    Current Research and Scholarly InterestsMedical Education, particularly the role of simulation (part-task trainers, human patient simulators and virtual reality) in the education of medical students and residents. Also, the use of the internet for distance learning in health care professions.

  • Christy Hartman

    Christy Hartman

    Program Manager, School of Medicine - Biomedical Ethics

    Current Role at StanfordProgram Manager, Medical Humanities and the Arts Program

  • Gary E Hartman, MD, MBA

    Gary E Hartman, MD, MBA

    Clinical Professor, Surgery - Pediatric Surgery
    Affiliate, Surgery - Pediatric Surgery

    Current Research and Scholarly InterestsMinimal Access and Robotic Surgery
    Neonatal Surgery
    Childhood Oncology

  • Mary Elizabeth Hartnett, MD

    Mary Elizabeth Hartnett, MD

    Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology

    BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.

    Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.

    Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.

    Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology. In recognition of her lifetime contributions, she was inducted into the Retina Hall of Fame and was elected to the Association of American Physicians in 2025.

    Dr. Hartnett's prolific publication record includes 295 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as the Treasurer for The Macula Society and the Chair of the Jack McGovern Coats Disease Foundation as well as the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO).

  • Stella Hartono

    Stella Hartono

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioStella Hartono, MD PhD is a board-certified allergy/immunology physician and clinical researcher. She specializes in diagnosing and treating immunology and allergic conditions, with a focus on immunodeficiency, immune dysregulation, hyper eosinophilia, and pet allergies.

    Dr. Hartono’s clinical research focuses on the role of age-associated B cells in vaccine response and the aging immune system. She is also interested in improving diagnosis and treatment options for patients with CVID (common variable immunodeficiency) and SAD (specific antibody deficiency). She has published her original research in peer-reviewed scientific journals and presented at national conferences, including annual meetings for the Clinical Immunology Society and the American Academy of Asthma, Allergy, and Immunology, as well as international conferences, including annual meeting for the European Academy of Allergy and Clinical Immunology. Dr. Hartono is a member of the American Academy of Asthma, Allergy, and Immunology, the Clinical Immunology Society, and the American College of Allergy, Asthma, and Immunology.

  • Grant Hartung

    Grant Hartung

    Affiliate, Rad/Radiological Sciences Laboratory

    BioMy research includes developing custom mathematical models and algorithms to comprehensively simulate the biophysics underlying brain dynamics. These models are then used to simulate the detailed blood flow, volume, and oxygenation changes that accompany neural activity with a focus on detailed, realistic microvascular geometry to predict the impact of hemodynamic states and vascular structure on fMRI signals (for BOLD and non-BOLD sequences). This interdisciplinary work includes advances in mathematics, biophysics, neuroscience, and computer science to enable simulations of vascular structures orders of magnitude larger than previously possible in only a few hours.
    These advancements have led to the quantification of many fMRI biases previously overlooked or undervalued. This includes the geometric blurring by the capillary bed between the site of neurovascular coupling and the venous response, ultimately measured by BOLD. Moreover, the microvascular blood volume at resting-state gave a non-neuronal explanation for the mid-cortex “bump” observed in layer-fMRI BOLD signals. This tool also proposed mechanistic explanations underlying the BOLD frequency nonlinearity observed during oscillatory stimulus. In non-BOLD acquisitions, these tools discovered artifacts in IntraVoxel Incoherent Motion (IVIM) and VAscular Space Occupancy (VASO) signals caused by vascular structural and flow asymmetries and velocity heterogeneity which help explain discrepancies in experimental findings with these methods.


    Google Scholar: https://scholar.google.com/citations?user=ihwU5t8AAAAJ&hl=en
    Email: grant.hartung@tu-darmstadt.de

  • Earth Hasassri, MD

    Earth Hasassri, MD

    Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Earth Hasassri is an Adjunct Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry and Child Development at Stanford University School of Medicine. He has a private practice in Menlo Park and teaches medical students, residents, and fellows at Stanford University School of Medicine. In his private practice, he specializes in seeing children and adults with complex psychiatric conditions such as ADHD, autism spectrum disorders, functional neurological disorders, those with epilepsy, and other neuropsychiatric conditions. His interests are caring for individuals who suffer from medical conditions at the interface of medicine and psychiatry.

    Prior to medical school, Dr. Hasassri graduated with dual bachelor's degrees in neurophysiology and psychology at the University of California San Diego, where he performed research on sleep medicine. He earned his medical degree from the Mayo Clinic Alix School of Medicine where he did research in clinical epidemiology. Dr. Hasassri completed his residency in general psychiatry at the University of California San Francisco Langley Porter Psychiatric Hospitals & Clinics, during which he was awarded an Area of Distinction in Clinical Neuroscience for his work in applying neuroscientific principles in his clinical work in those with brain cancer, dementia, neurodevelopmental disorders, and other neuropsychiatric conditions. Dr. Hasassri is dual board certified in adult psychiatry and in child and adolescent psychiatry through the American Board of Psychiatry and Neurology, a member Board of the American Board of Medical Specialties.

  • Hoda Hashemi

    Hoda Hashemi

    Postdoctoral Scholar, Radiological Sciences Laboratory

    BioHoda S. Hashemi is a postdoctoral scholar at the Ultrasound Imaging & Instrumentation Lab at Stanford University. She received her PhD in Electrical and Computer Engineering from the University of British Columbia (UBC) in 2023. She was also an ultrasound research intern in research and innovation team at DarkVision Technologies Inc. from 2021 to 2023. She holds a M.A.Sc. from Concordia University and a B.Sc. from Sharif University of Technology. Her research interests are ultrasound molecular imaging, elastography and AI in medical image processing. Her research has been funded by the NIH T32 Fellowship at Stanford, the Canadian NSERC Postdoctoral Fellowship, and the Ultrasound Imaging & Instrumentation Lab at Stanford University.

  • William Haskell

    William Haskell

    Professor (Research) of Medicine, Emeritus

    Current Research and Scholarly InterestsMy major research interests and activities over the next several years will focus on the development and evaluation of the objective measurement of physical activity in free-living populations using a variety of sensing devices and mobile phones for data collection and processing. Also, I will continue to direct the Stanford Heart Network with the major mission being to assist community-based CVD prevention/treatment programs implement more effective heart attack and stroke prevention programs.

  • Trevor Hastie

    Trevor Hastie

    John A. Overdeck Professor, Professor of Statistics and of Biomedical Data Sciences, Emeritus

    Current Research and Scholarly InterestsFlexible statistical modeling for prediction and representation of data arising in biology, medicine, science or industry. Statistical and machine learning tools have gained importance over the years. Part of Hastie's work has been to bridge the gap between traditional statistical methodology and the achievements made in machine learning.

  • Sejal Tyle Hathi, MD MBA

    Sejal Tyle Hathi, MD MBA

    Clinical Assistant Professor, Medicine

    BioDr. Sejal Tyle Hathi is a board-certified physician and nationally recognized public health leader with more than 15 years of experience advancing physical and mental health, women's rights, and public policy in the United States and globally.

    She serves as the 4th permanent Director of the Oregon Health Authority, appointed by Governor Tina Kotek and unanimously confirmed by the Oregon Senate to oversee all health care and public health services, policies, and programs for the State of Oregon. Most recently, she served as New Jersey's deputy health commissioner and state health officer — a position she held after two years as the Biden White House's Senior Policy Advisor for Public Health, where she led several presidential priorities across mental health, climate and health, public health preparedness, and supply chain policy. She has also held joint faculty appointments as an assistant professor of medicine at the Johns Hopkins School of Medicine & Bloomberg School of Public Health.

    Dr. Hathi grew up in Fremont, California and received her B.S. with honors from Yale University and her M.D. / M.B.A. from Stanford University, where she studied as a Harry S. Truman Scholar and Paul & Daisy Soros Fellow. She completed her clinical training in internal medicine and primary care at Harvard Medical School and the Massachusetts General Hospital.

  • Nancy A. Haug

    Nancy A. Haug

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PAU-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.

    Dr. Haug chairs the American Psychological Association (APA) Ethics Committee and formerly served on the California Psychological Association Ethics Committee. She is a Fellow, Member-at-Large for Practice, and President- Elect of the Society of Addiction Psychology (Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.

    Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis.

  • Michelle Hauser, MD, MS, MPA, FACP, FACLM, DipABLM, DABOM, Chef

    Michelle Hauser, MD, MS, MPA, FACP, FACLM, DipABLM, DABOM, Chef

    Clinical Associate Professor, Surgery - General Surgery

    Current Research and Scholarly InterestsPrimary care physician, prevention researcher, medical educator and classically-trained chef who combines these fields to move people away from diets that lead to chronic disease and toward eating delicious food that promotes health and well-being.

  • Kristina Elizabeth Hawk

    Kristina Elizabeth Hawk

    Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine

    BioKristina Elizabeth Hawk, MS MD PhD is a Nuclear Medicine Physician and Neuroradiologist. As a physician scientist, integrated MD/PhD training helped build a foundation to explore translational research efforts, using a full and intricate understanding of the research process, and the developed ability to understand, discuss and teach new emerging concepts. Dr. Hawk’s dissertation in Neuroscience focused on the regulation of Nitric Oxide Synthase in the dorsal and ventral striatum, exploring the neurochemical role of nitric oxide producing interneurons, and their ability to coordinate dopaminergic and glutamatergic signaling in areas of the brain relevant to cognition and motivated behavior.

    Eager to expand her passion into the field of Medical Radiation Physics, she also completed a separate Masters degree in Medical Radiation Physics. This provided her with in depth training of how therapeutic and diagnostic instruments use both ionizing and non-ionizing radiation in the clinical setting. She then completed her Medical Doctorate and Diagnostic Radiology Residency at the University of Southern California (USC), learning the art of medicine while serving the diverse population at Los Angeles County Hospital.

    Dr. Hawk completed clinical fellowship requirements in Nuclear Medicine at USC, and is now Board Certified by the American Board of Nuclear Medicine. She also completed a Neuroradiology fellowship at USC, and is Board Certified the American Board of Radiology. She served as both the Chief Resident and Chief Neuroradiology Fellow.

    Dr. Hawk has held multiple local and national leadership positions, including positions in the American College of Radiology (ACR), the American College of Nuclear Medicine (ACNM) and the Society of Nuclear and Molecular Medicine (SNMMI). Dr. Hawk is an editorial board member of the Journal of the American College of Radiology (JACR). She has served as the Vice-Chair for Education for the Nuclear Medicine Resident Organization of the ACNM, and the Educational Liaison for the Resident and Fellow Section of the ACR. Currently, she serves on the national ACR Commission for Women and General Diversity as well as the ACR Commission on Nuclear Medicine. Dr. Hawk also sits on the ACR Council Steering Committee.

    Dr. Hawk is committed to continually exploring the beautiful applications of ionizing and non-ionizing radiation to image and treat the human body.